Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects*; D002421:Caudate Nucleus / Q000032:analysis; D002531:Cerebellum / Q000032:analysis; D002540:Cerebral Cortex / Q000032:analysis; D004298:Dopamine / Q000032:analysis*; D000882:Haplorhini; D006801:Humans; D007031:Hypothalamus / Q000032:analysis; D007490:Iproniazid / Q000494:pharmacology; D008251:Macaca; D008526:Medulla Oblongata / Q000032:analysis; D008636:Mesencephalon / Q000032:analysis; D008750:Methyldopa / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology*; D009638:Norepinephrine / Q000032:analysis*; D011149:Pons / Q000032:analysis; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis*; D013116:Spinal Cord / Q000032:analysis; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders; D013788:Thalamus / Q000032:analysis; D013797:Thebaine / Q000494:pharmacology
D013797:Thebaine; D012701:Serotonin; D008750:Methyldopa; D009020:Morphine; D012110:Reserpine; D007490:Iproniazid; D004298:Dopamine; D009638:Norepinephrine